Drug Price Versus Value: British Pharma Plans Public Debate In November
Executive Summary
Having called for a public debate on how the United Kingdom values and provides access to new medicines, the Association of the British Pharmaceutical Industry is organizing to make it happen
You may also be interested in...
U.K. Seeks Flexible Drug Pricing; NICE Becomes Flexible On Value
The British government and pharmaceutical industry are negotiating a pricing system that allows the National Health Service to pay more for a drug as its value is demonstrated in clinical practice
U.K. Seeks Flexible Drug Pricing; NICE Becomes Flexible On Value
The British government and pharmaceutical industry are negotiating a pricing system that allows the National Health Service to pay more for a drug as its value is demonstrated in clinical practice
NICE To Adjust Drug Appraisal Standards So Terminally Ill Patients Can Access More Therapies
Proposed cost-effectiveness criteria allow medicines in U.K. to be judged on ability to substantially extend life.